2018-2023 Global Tasigna Drug Consumption Market Report

August 2018 | 131 pages | ID: 20D07097BA5EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Tasigna Drug market for 2018-2023.
Nilotinib in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the treatment of imatinib-resistant chronic myelogenous leukemia.

Over the next five years, LPI(LP Information) projects that Tasigna Drug will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Tasigna Drug market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• 50mg
• 200mg
• Other

Segmentation by application:

• Hospital
• Drugs Store
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Tasigna Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Tasigna Drug market by identifying its various subsegments.
• Focuses on the key global Tasigna Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Tasigna Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Tasigna Drug submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL TASIGNA DRUG CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Tasigna Drug Consumption 2013-2023
  2.1.2 Tasigna Drug Consumption CAGR by Region
2.2 Tasigna Drug Segment by Type
  2.2.1 50mg
  2.2.2 200mg
  2.2.3 Other
2.3 Tasigna Drug Consumption by Type
  2.3.1 Global Tasigna Drug Consumption Market Share by Type (2013-2018)
  2.3.2 Global Tasigna Drug Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Tasigna Drug Sale Price by Type (2013-2018)
2.4 Tasigna Drug Segment by Application
  2.4.1 Hospital
  2.4.2 Drugs Store
  2.4.3 Other
2.5 Tasigna Drug Consumption by Application
  2.5.1 Global Tasigna Drug Consumption Market Share by Application (2013-2018)
  2.5.2 Global Tasigna Drug Value and Market Share by Application (2013-2018)
  2.5.3 Global Tasigna Drug Sale Price by Application (2013-2018)

3 GLOBAL TASIGNA DRUG BY PLAYERS

3.1 Global Tasigna Drug Sales Market Share by Players
  3.1.1 Global Tasigna Drug Sales by Players (2016-2018)
  3.1.2 Global Tasigna Drug Sales Market Share by Players (2016-2018)
3.2 Global Tasigna Drug Revenue Market Share by Players
  3.2.1 Global Tasigna Drug Revenue by Players (2016-2018)
  3.2.2 Global Tasigna Drug Revenue Market Share by Players (2016-2018)
3.3 Global Tasigna Drug Sale Price by Players
3.4 Global Tasigna Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Tasigna Drug Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Tasigna Drug Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 TASIGNA DRUG BY REGIONS

4.1 Tasigna Drug by Regions
  4.1.1 Global Tasigna Drug Consumption by Regions
  4.1.2 Global Tasigna Drug Value by Regions
4.2 Americas Tasigna Drug Consumption Growth
4.3 APAC Tasigna Drug Consumption Growth
4.4 Europe Tasigna Drug Consumption Growth
4.5 Middle East & Africa Tasigna Drug Consumption Growth

5 AMERICAS

5.1 Americas Tasigna Drug Consumption by Countries
  5.1.1 Americas Tasigna Drug Consumption by Countries (2013-2018)
  5.1.2 Americas Tasigna Drug Value by Countries (2013-2018)
5.2 Americas Tasigna Drug Consumption by Type
5.3 Americas Tasigna Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Tasigna Drug Consumption by Countries
  6.1.1 APAC Tasigna Drug Consumption by Countries (2013-2018)
  6.1.2 APAC Tasigna Drug Value by Countries (2013-2018)
6.2 APAC Tasigna Drug Consumption by Type
6.3 APAC Tasigna Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Tasigna Drug by Countries
  7.1.1 Europe Tasigna Drug Consumption by Countries (2013-2018)
  7.1.2 Europe Tasigna Drug Value by Countries (2013-2018)
7.2 Europe Tasigna Drug Consumption by Type
7.3 Europe Tasigna Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Tasigna Drug by Countries
  8.1.1 Middle East & Africa Tasigna Drug Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Tasigna Drug Value by Countries (2013-2018)
8.2 Middle East & Africa Tasigna Drug Consumption by Type
8.3 Middle East & Africa Tasigna Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Tasigna Drug Distributors
10.3 Tasigna Drug Customer

11 GLOBAL TASIGNA DRUG MARKET FORECAST

11.1 Global Tasigna Drug Consumption Forecast (2018-2023)
11.2 Global Tasigna Drug Forecast by Regions
  11.2.1 Global Tasigna Drug Forecast by Regions (2018-2023)
  11.2.2 Global Tasigna Drug Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Tasigna Drug Forecast by Type
11.8 Global Tasigna Drug Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Novartis
  12.1.1 Company Details
  12.1.2 Tasigna Drug Product Offered
  12.1.3 Novartis Tasigna Drug Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Novartis News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Tasigna Drug
Table Product Specifications of Tasigna Drug
Figure Tasigna Drug Report Years Considered
Figure Market Research Methodology
Figure Global Tasigna Drug Consumption Growth Rate 2013-2023 (K Units)
Figure Global Tasigna Drug Value Growth Rate 2013-2023 ($ Millions)
Table Tasigna Drug Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of 50mg
Table Major Players of 50mg
Figure Product Picture of 200mg
Table Major Players of 200mg
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Tasigna Drug Consumption Market Share by Type (2013-2018)
Figure Global Tasigna Drug Consumption Market Share by Type (2013-2018)
Table Global Tasigna Drug Revenue by Type (2013-2018) ($ million)
Table Global Tasigna Drug Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Tasigna Drug Value Market Share by Type (2013-2018)
Table Global Tasigna Drug Sale Price by Type (2013-2018)
Figure Tasigna Drug Consumed in Hospital
Figure Global Tasigna Drug Market: Hospital (2013-2018) (K Units)
Figure Global Tasigna Drug Market: Hospital (2013-2018) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Tasigna Drug Consumed in Drugs Store
Figure Global Tasigna Drug Market: Drugs Store (2013-2018) (K Units)
Figure Global Tasigna Drug Market: Drugs Store (2013-2018) ($ Millions)
Figure Global Drugs Store YoY Growth ($ Millions)
Figure Tasigna Drug Consumed in Other
Figure Global Tasigna Drug Market: Other (2013-2018) (K Units)
Figure Global Tasigna Drug Market: Other (2013-2018) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Tasigna Drug Consumption Market Share by Application (2013-2018)
Figure Global Tasigna Drug Consumption Market Share by Application (2013-2018)
Table Global Tasigna Drug Value by Application (2013-2018)
Table Global Tasigna Drug Value Market Share by Application (2013-2018)
Figure Global Tasigna Drug Value Market Share by Application (2013-2018)
Table Global Tasigna Drug Sale Price by Application (2013-2018)
Table Global Tasigna Drug Sales by Players (2016-2018) (K Units)
Table Global Tasigna Drug Sales Market Share by Players (2016-2018)
Figure Global Tasigna Drug Sales Market Share by Players in 2016
Figure Global Tasigna Drug Sales Market Share by Players in 2017
Table Global Tasigna Drug Revenue by Players (2016-2018) ($ Millions)
Table Global Tasigna Drug Revenue Market Share by Players (2016-2018)
Figure Global Tasigna Drug Revenue Market Share by Players in 2016
Figure Global Tasigna Drug Revenue Market Share by Players in 2017
Table Global Tasigna Drug Sale Price by Players (2016-2018)
Figure Global Tasigna Drug Sale Price by Players in 2017
Table Global Tasigna Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Tasigna Drug Products Offered
Table Tasigna Drug Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Tasigna Drug Consumption by Regions 2013-2018 (K Units)
Table Global Tasigna Drug Consumption Market Share by Regions 2013-2018
Figure Global Tasigna Drug Consumption Market Share by Regions 2013-2018
Table Global Tasigna Drug Value by Regions 2013-2018 ($ Millions)
Table Global Tasigna Drug Value Market Share by Regions 2013-2018
Figure Global Tasigna Drug Value Market Share by Regions 2013-2018
Figure Americas Tasigna Drug Consumption 2013-2018 (K Units)
Figure Americas Tasigna Drug Value 2013-2018 ($ Millions)
Figure APAC Tasigna Drug Consumption 2013-2018 (K Units)
Figure APAC Tasigna Drug Value 2013-2018 ($ Millions)
Figure Europe Tasigna Drug Consumption 2013-2018 (K Units)
Figure Europe Tasigna Drug Value 2013-2018 ($ Millions)
Figure Middle East & Africa Tasigna Drug Consumption 2013-2018 (K Units)
Figure Middle East & Africa Tasigna Drug Value 2013-2018 ($ Millions)
Table Americas Tasigna Drug Consumption by Countries (2013-2018) (K Units)
Table Americas Tasigna Drug Consumption Market Share by Countries (2013-2018)
Figure Americas Tasigna Drug Consumption Market Share by Countries in 2017
Table Americas Tasigna Drug Value by Countries (2013-2018) ($ Millions)
Table Americas Tasigna Drug Value Market Share by Countries (2013-2018)
Figure Americas Tasigna Drug Value Market Share by Countries in 2017
Table Americas Tasigna Drug Consumption by Type (2013-2018) (K Units)
Table Americas Tasigna Drug Consumption Market Share by Type (2013-2018)
Figure Americas Tasigna Drug Consumption Market Share by Type in 2017
Table Americas Tasigna Drug Consumption by Application (2013-2018) (K Units)
Table Americas Tasigna Drug Consumption Market Share by Application (2013-2018)
Figure Americas Tasigna Drug Consumption Market Share by Application in 2017
Figure United States Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure United States Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Canada Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Canada Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Mexico Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Mexico Tasigna Drug Value Growth 2013-2018 ($ Millions)
Table APAC Tasigna Drug Consumption by Countries (2013-2018) (K Units)
Table APAC Tasigna Drug Consumption Market Share by Countries (2013-2018)
Figure APAC Tasigna Drug Consumption Market Share by Countries in 2017
Table APAC Tasigna Drug Value by Countries (2013-2018) ($ Millions)
Table APAC Tasigna Drug Value Market Share by Countries (2013-2018)
Figure APAC Tasigna Drug Value Market Share by Countries in 2017
Table APAC Tasigna Drug Consumption by Type (2013-2018) (K Units)
Table APAC Tasigna Drug Consumption Market Share by Type (2013-2018)
Figure APAC Tasigna Drug Consumption Market Share by Type in 2017
Table APAC Tasigna Drug Consumption by Application (2013-2018) (K Units)
Table APAC Tasigna Drug Consumption Market Share by Application (2013-2018)
Figure APAC Tasigna Drug Consumption Market Share by Application in 2017
Figure China Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure China Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Japan Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Japan Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Korea Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Korea Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure India Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure India Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Australia Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Australia Tasigna Drug Value Growth 2013-2018 ($ Millions)
Table Europe Tasigna Drug Consumption by Countries (2013-2018) (K Units)
Table Europe Tasigna Drug Consumption Market Share by Countries (2013-2018)
Figure Europe Tasigna Drug Consumption Market Share by Countries in 2017
Table Europe Tasigna Drug Value by Countries (2013-2018) ($ Millions)
Table Europe Tasigna Drug Value Market Share by Countries (2013-2018)
Figure Europe Tasigna Drug Value Market Share by Countries in 2017
Table Europe Tasigna Drug Consumption by Type (2013-2018) (K Units)
Table Europe Tasigna Drug Consumption Market Share by Type (2013-2018)
Figure Europe Tasigna Drug Consumption Market Share by Type in 2017
Table Europe Tasigna Drug Consumption by Application (2013-2018) (K Units)
Table Europe Tasigna Drug Consumption Market Share by Application (2013-2018)
Figure Europe Tasigna Drug Consumption Market Share by Application in 2017
Figure Germany Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Germany Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure France Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure France Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure UK Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure UK Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Italy Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Italy Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Russia Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Russia Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Spain Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Spain Tasigna Drug Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Tasigna Drug Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Tasigna Drug Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Tasigna Drug Consumption Market Share by Countries in 2017
Table Middle East & Africa Tasigna Drug Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Tasigna Drug Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Tasigna Drug Value Market Share by Countries in 2017
Table Middle East & Africa Tasigna Drug Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Tasigna Drug Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Tasigna Drug Consumption Market Share by Type in 2017
Table Middle East & Africa Tasigna Drug Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Tasigna Drug Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Tasigna Drug Consumption Market Share by Application in 2017
Figure Egypt Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Egypt Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure South Africa Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure South Africa Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Israel Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Israel Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure Turkey Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure Turkey Tasigna Drug Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Tasigna Drug Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Tasigna Drug Value Growth 2013-2018 ($ Millions)
Table Tasigna Drug Distributors List
Table Tasigna Drug Customer List
Figure Global Tasigna Drug Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Tasigna Drug Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Tasigna Drug Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Tasigna Drug Consumption Market Forecast by Regions
Table Global Tasigna Drug Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Tasigna Drug Value Market Share Forecast by Regions
Figure Americas Tasigna Drug Consumption 2018-2023 (K Units)
Figure Americas Tasigna Drug Value 2018-2023 ($ Millions)
Figure APAC Tasigna Drug Consumption 2018-2023 (K Units)
Figure APAC Tasigna Drug Value 2018-2023 ($ Millions)
Figure Europe Tasigna Drug Consumption 2018-2023 (K Units)
Figure Europe Tasigna Drug Value 2018-2023 ($ Millions)
Figure Middle East & Africa Tasigna Drug Consumption 2018-2023 (K Units)
Figure Middle East & Africa Tasigna Drug Value 2018-2023 ($ Millions)
Figure United States Tasigna Drug Consumption 2018-2023 (K Units)
Figure United States Tasigna Drug Value 2018-2023 ($ Millions)
Figure Canada Tasigna Drug Consumption 2018-2023 (K Units)
Figure Canada Tasigna Drug Value 2018-2023 ($ Millions)
Figure Mexico Tasigna Drug Consumption 2018-2023 (K Units)
Figure Mexico Tasigna Drug Value 2018-2023 ($ Millions)
Figure Brazil Tasigna Drug Consumption 2018-2023 (K Units)
Figure Brazil Tasigna Drug Value 2018-2023 ($ Millions)
Figure China Tasigna Drug Consumption 2018-2023 (K Units)
Figure China Tasigna Drug Value 2018-2023 ($ Millions)
Figure Japan Tasigna Drug Consumption 2018-2023 (K Units)
Figure Japan Tasigna Drug Value 2018-2023 ($ Millions)
Figure Korea Tasigna Drug Consumption 2018-2023 (K Units)
Figure Korea Tasigna Drug Value 2018-2023 ($ Millions)
Figure Southeast Asia Tasigna Drug Consumption 2018-2023 (K Units)
Figure Southeast Asia Tasigna Drug Value 2018-2023 ($ Millions)
Figure India Tasigna Drug Consumption 2018-2023 (K Units)
Figure India Tasigna Drug Value 2018-2023 ($ Millions)
Figure Australia Tasigna Drug Consumption 2018-2023 (K Units)
Figure Australia Tasigna Drug Value 2018-2023 ($ Millions)
Figure Germany Tasigna Drug Consumption 2018-2023 (K Units)
Figure Germany Tasigna Drug Value 2018-2023 ($ Millions)
Figure France Tasigna Drug Consumption 2018-2023 (K Units)
Figure France Tasigna Drug Value 2018-2023 ($ Millions)
Figure UK Tasigna Drug Consumption 2018-2023 (K Units)
Figure UK Tasigna Drug Value 2018-2023 ($ Millions)
Figure Italy Tasigna Drug Consumption 2018-2023 (K Units)
Figure Italy Tasigna Drug Value 2018-2023 ($ Millions)
Figure Russia Tasigna Drug Consumption 2018-2023 (K Units)
Figure Russia Tasigna Drug Value 2018-2023 ($ Millions)
Figure Spain Tasigna Drug Consumption 2018-2023 (K Units)
Figure Spain Tasigna Drug Value 2018-2023 ($ Millions)
Figure Egypt Tasigna Drug Consumption 2018-2023 (K Units)
Figure Egypt Tasigna Drug Value 2018-2023 ($ Millions)
Figure South Africa Tasigna Drug Consumption 2018-2023 (K Units)
Figure South Africa Tasigna Drug Value 2018-2023 ($ Millions)
Figure Israel Tasigna Drug Consumption 2018-2023 (K Units)
Figure Israel Tasigna Drug Value 2018-2023 ($ Millions)
Figure Turkey Tasigna Drug Consumption 2018-2023 (K Units)
Figure Turkey Tasigna Drug Value 2018-2023 ($ Millions)
Figure GCC Countries Tasigna Drug Consumption 2018-2023 (K Units)
Figure GCC Countries Tasigna Drug Value 2018-2023 ($ Millions)
Table Global Tasigna Drug Consumption Forecast by Type (2018-2023) (K Units)
Table Global Tasigna Drug Consumption Market Share Forecast by Type (2018-2023)
Table Global Tasigna Drug Value Forecast by Type (2018-2023) ($ Millions)
Table Global Tasigna Drug Value Market Share Forecast by Type (2018-2023)
Table Global Tasigna Drug Consumption Forecast by Application (2018-2023) (K Units)
Table Global Tasigna Drug Consumption Market Share Forecast by Application (2018-2023)
Table Global Tasigna Drug Value Forecast by Application (2018-2023) ($ Millions)
Table Global Tasigna Drug Value Market Share Forecast by Application (2018-2023)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Tasigna Drug Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Tasigna Drug Market Share (2016-2018)